Wellington Q1 2026 Preview: Will the Defensive Refill Outlast the AI Core?

Wellington's next 13F should reveal whether its late-2025 defensive refill was a temporary balance move or the start of a more durable portfolio tilt. The last reported baseline still matters because it kept the AI-heavy top book intact while rotating fresh capital into steadier healthcare and consumer franchises.

Wellington Management Group did not abandon the dominant U.S. growth trade in 2025Q4. The filing still opened with Nvidia, Microsoft, Apple, Alphabet, and Broadcom. Those five names alone defined almost one-fifth of the visible 500-line book. Anyone looking for a clean anti-AI rotation would not find it here.

But Wellington's quarter was not a passive hold either. The manager opened 70 visible positions, exited 70, and filled the incoming list with a noticeably more defensive mix led by Unilever, Intuitive Surgical, Edwards Lifesciences, Cencora, and American Water Works. It also increased Merck 15% and Amazon 13% while cutting Boeing, Chewy, and Apple. The result is a filing that kept an AI core but improved the portfolio's shock absorbers.

The Top of the Book Stayed Familiar

The first chart makes Wellington's top-line identity plain. Nvidia remained the largest position at $26.24 billion, followed by Microsoft at $23.65 billion and Apple at $21.02 billion. That is not what a full retreat from growth looks like. Even after trims to Apple and Alphabet, the manager still carried a very recognizable mega-cap platform basket.

The concentration chart shows why the rest of the rotation matters. The top ten names represent about 29.5% of the filing, leaving more than 70% spread across the tail. Wellington did not need to slash its largest technology names to reshape portfolio resilience. It could preserve the high-conviction winners while quietly changing the lower layers of the book.

The New Positions Tell the Real Story

Unilever, Intuitive Surgical, Edwards Lifesciences, Cencora, and American Water Works are not the names investors expect to define a quarter still led by Nvidia. That is exactly why they matter. Wellington used the period to add steadier cash-flow and healthcare exposures without surrendering its exposure to platform winners. It also lifted Merck, Mastercard, DoorDash, and Netflix while reducing Boeing and several more cyclical or rate-sensitive names.

This looks less like a macro call against technology and more like risk budgeting. Wellington's AUM barely changed quarter over quarter, slipping 0.1% in the visible sum while reported totalAum held near $570.7 billion. In that environment, new defensive positions can be read as portfolio construction choices rather than forced refuges. The manager was not panicking. It was tuning.

The History Chart Shows Why the Refill Matters

Wellington's 13F value has oscillated in a relatively tight band since 2024, rising to $571.3 billion in 2025Q3 and ending 2025Q4 at $570.7 billion. That kind of plateau often pushes managers toward internal quality upgrades rather than wholesale repositioning. The history chart makes the point visually: the fund is large, mature, and still growing over the medium term, but quarterly changes are no longer driven by one dramatic swing.

Against that backdrop, the 70 new positions and 70 exits become more meaningful. Wellington was not trying to discover a new identity. It was trying to preserve return optionality while improving the portfolio's ability to hold up if the same handful of tech winners stop carrying everything.

How to Read Wellington Relative to Peers

Compared with FMR and Capital World Investors, Wellington's quarter looks less about chasing a new digital platform winner and more about balancing a large institutional book. Compared with Capital International Investors, it put less emphasis on one dominant anchor like Broadcom and more emphasis on spreading fresh capital across healthcare and defensive franchises. That does not make Wellington cautious in a vacuum. It makes it selectively cautious at the margin.

The best next-quarter checklist is therefore simple. Watch whether Merck and the new healthcare names scale higher. Watch whether Boeing and Chewy continue to shrink. And watch whether Nvidia, Microsoft, and Apple remain firmly in place. If they do, Wellington's Q4 2025 filing will look like what it probably was: a disciplined defensive refill wrapped around an AI-era core it still trusts.